Skip to main content
. 2023 Jan 19;15(2):97. doi: 10.3390/toxins15020097

Figure 2.

Figure 2

Severe COVID-19 rate during follow-up, according to baseline plasma FGF23 levels. Cumulative incidence of severe COVID-19 in end-stage renal disease patients in hemodialysis. Severe COVID-19 is defined as the requirements for hospitalizations or COVID-related deaths. Patients were classified according to baseline plasma intact FGF23 levels: low FGF23 (n = 121—blue line) and high FGF23 (n = 122—red line).